BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8267795)

  • 1. Interleukin 1 receptor antagonist inhibits the augmentation of metastasis induced by interleukin 1 or lipopolysaccharide in a human melanoma/nude mouse system.
    Chirivi RG; Garofalo A; Padura IM; Mantovani A; Giavazzi R
    Cancer Res; 1993 Oct; 53(20):5051-4. PubMed ID: 8267795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice.
    Giavazzi R; Garofalo A; Bani MR; Abbate M; Ghezzi P; Boraschi D; Mantovani A; Dejana E
    Cancer Res; 1990 Aug; 50(15):4771-5. PubMed ID: 2196116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastases.
    Garofalo A; Chirivi RG; Foglieni C; Pigott R; Mortarini R; Martin-Padura I; Anichini A; Gearing AJ; Sanchez-Madrid F; Dejana E
    Cancer Res; 1995 Jan; 55(2):414-9. PubMed ID: 7529137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of interleukin 1 receptor antagonist gene transduction on human melanoma xenografts in nude mice.
    Weinreich DM; Elaraj DM; Puhlmann M; Hewitt SM; Carroll NM; Feldman ED; Turner EM; Spiess PJ; Alexander HR
    Cancer Res; 2003 Sep; 63(18):5957-61. PubMed ID: 14522922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
    Huang S; Xie K; Bucana CD; Ullrich SE; Bar-Eli M
    Clin Cancer Res; 1996 Dec; 2(12):1969-79. PubMed ID: 9816156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
    Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
    Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 receptor blockade reduces the number and size of murine B16 melanoma hepatic metastases.
    Vidal-Vanaclocha F; Amézaga C; Asumendi A; Kaplanski G; Dinarello CA
    Cancer Res; 1994 May; 54(10):2667-72. PubMed ID: 8168095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 receptor antagonist inhibits subcutaneous B16 melanoma growth in vivo.
    McKenzie RC; Oran A; Dinarello CA; Sauder DN
    Anticancer Res; 1996; 16(1):437-41. PubMed ID: 8615650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient.
    Doucet C; Meazza R; Pottin-Clemenceau C; Scudeletti M; Brouty-Boye D; Ferrini S; Alileche A; Taoufik Y; Jasmin C; Azzarone B; Indiveri F
    Melanoma Res; 1997 Aug; 7 Suppl 2():S7-17. PubMed ID: 9578412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained delivery of IL-1 Ra from biodegradable microspheres reduces the number of murine B16 melanoma lung metastases.
    Lavi G; Voronov E; Dinarello CA; Apte RN; Cohen S
    J Control Release; 2007 Nov; 123(2):123-30. PubMed ID: 17900737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii.
    Ricci S; Macchia G; Ruggiero P; Maggi T; Bossù P; Xu L; Medaglini D; Tagliabue A; Hammarström L; Pozzi G; Boraschi D
    BMC Biotechnol; 2003 Sep; 3():15. PubMed ID: 13129437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo.
    Gabay C; Porter B; Fantuzzi G; Arend WP
    J Immunol; 1997 Dec; 159(12):5905-13. PubMed ID: 9550387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of interleukin 1 in growth and metastasis of human cancer xenografts.
    Elaraj DM; Weinreich DM; Varghese S; Puhlmann M; Hewitt SM; Carroll NM; Feldman ED; Turner EM; Alexander HR
    Clin Cancer Res; 2006 Feb; 12(4):1088-96. PubMed ID: 16489061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1 receptor antagonist inhibits the hypercalcemia mediated by interleukin-1.
    Guise TA; Garrett IR; Bonewald LF; Mundy GR
    J Bone Miner Res; 1993 May; 8(5):583-7. PubMed ID: 8511985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The inhibition effect of interleukin-1 receptor antagonist on interleukin-1 alpha-induced intercellular adhesion molecule-1 expression on orbital fibroblasts and adhesion of peripheral blood mononuclear cells].
    Liu GQ; Wu ZY; Yang HS; Zheng JL; Lin Z
    Zhonghua Yan Ke Za Zhi; 2003 Sep; 39(9):528-32. PubMed ID: 14766082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of granuloma formation induced by potassium permanganate in the mouse by a specific human recombinant receptor antagonist for interleukin-1 (hrIL-1ra).
    Conti P; Panara MR; Fridas S; Barbacane RC; Grilli A; Placido FC; Reale M; Fiore S
    Cell Immunol; 1993 Apr; 147(2):446-57. PubMed ID: 8384086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor and immunotherapeutic effects of activated invasive T lymphoma cells that display short-term interleukin 1alpha expression.
    Voronov E; Weinstein Y; Benharroch D; Cagnano E; Ofir R; Dobkin M; White RM; Zoller M; Barak V; Segal S; Apte RN
    Cancer Res; 1999 Mar; 59(5):1029-35. PubMed ID: 10070959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
    La E; Muga SJ; Locniskar MF; Fischer SM
    Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of interleukin-1 beta and interleukin-1 receptor antagonist in oxLDL-treated human aortic smooth muscle cells and in the neointima of cholesterol-fed endothelia-denuded rabbits.
    Lin SJ; Yen HT; Chen YH; Ku HH; Lin FY; Chen YL
    J Cell Biochem; 2003 Mar; 88(4):836-47. PubMed ID: 12577317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory effects of hepatocyte growth factor: induction of interleukin-1 receptor antagonist.
    Molnar C; Garcia-Trevijano ER; Ludwiczek O; Talabot D; Kaser A; Mato JM; Fritsche G; Weiss G; Gabay C; Avila MA; Tilg H
    Eur Cytokine Netw; 2004; 15(4):303-11. PubMed ID: 15627638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.